EC
ZVSA

Elequin Capital’s ZyVersa Therapeutics ZVSA Stock Holding History

Elequin Capital’s Portfolio ZVSA Stock Details ZVSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3
Closed -$10K – 739
2022
Q3 		$10K Buy
+3
New +$10.5K ﹤0.01% 247

Other funds holding ZVSA

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

Elequin Capital's ZVSA Position: Q4 2022 in Review

Elequin Capital sold out of ZyVersa Therapeutics (ZVSA) in Q4 2022, closing a stake of 3 shares — an estimated $10K sold.

Elequin Capital first reported a position in ZVSA in Q3 2022 and held it in 1 quarter. The position peaked at $10K in Q3 2022. 2 funds tracked by Wall St. Rank hold ZVSA as of Q4 2022.

  • Elequin Capital reported no remaining ZyVersa Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Elequin Capital sold 3 ZyVersa Therapeutics shares in Q4 2022, an estimated $10K.
  • Elequin Capital first reported a position in ZyVersa Therapeutics in Q3 2022 and held it in 1 quarter.
  • Elequin Capital's ZyVersa Therapeutics position peaked at $10K in Q3 2022.
  • 2 funds tracked by Wall St. Rank held ZyVersa Therapeutics as of Q4 2022.

Based on Elequin Capital's 13F filing for Q4 2022, filed 9 Feb 2023.